Logo Image
|Poll|March 22, 2019

Mini Quiz: Neurobiology of Borderline Personality Disorder

What do functional magnetic resonance neuroimaging findings reveal about the neurobiology of borderline personality disorder? Take the quiz and learn more.

Which of the following statements about the neurobiology of borderline personality disorder is supported by functional magnetic resonance neuroimaging?

A. Hyperactivity of the amygdala and prefontal cortex is characteristic of patients with BPD.
B. Increased acetylcholine activity in the hippocampus and neocortex accounts for impulsive aggression in patients with BPD.
C. Treatment of BPD with oxytocin increases hypermentalization by decreasing activity in the prefrontal cortex.
D. Use of emotion regulation strategies taught in DBT correlates with decreased activity in the amygdala.
E. fMRI studies show that affective, cognitive, behavioral, and interpersonal difficulties are inherited rather than BPD itself.

Related Content

Latest CME

Jersey City Psychiatry
In-Person Event

Jersey City Psychiatry

October 2-3, 2026

Register now!
Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care
Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

View more
Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia
Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

View more
(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia
Video

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

View more
Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder
Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

View more
Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia
Video

Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia

Gus Alva, MD, DFAPA; Erin Crown, MHS, PA-C

View more